The Editor's Roundtable: Advances in Myocardial Perfusion Imaging

  • Vincent E. Friedewald
    Correspondence
    Corresponding author: Tel: 574-631-6675; fax 574-631-4505
    Affiliations
    Associate Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Ami E. Iskandrian
    Affiliations
    Distinguished Professor of Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Alabama
    Search for articles by this author
  • John J. Mahmarian
    Affiliations
    Professor of Medicine, Weill Cornell Medical College Department of Cardiology, The Methodist Hospital, Houston, Texas
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
      This CME activity is supported by an educational grant from Astellas Pharma US, LLC, Deerfield, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Cardiology Carrier Advisory Committee, American Society of Nuclear Cardiology
        A model LCD: LCD information: single photon myocardial perfusion imaging.
        (Accessed September 11, 2008)
        • Zaret B.L.
        • Strauss H.W.
        • Martin N.D.
        • Wells Jr, H.P.
        • Flamm Jr, M.D.
        Noninvasive regional myocardial perfusion with radioactive potassium.
        N Engl J Med. 1973; 288: 809-812
        • Hendel R.C.
        • Bateman T.M.
        • Cerqueria M.D.
        • Iskandrian A.E.
        • Leppo J.A.
        • Blackburn B.
        • Mahmarian J.J.
        Initial clinical experience with regadenoson, a novel A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
        J Am Coll Cardiol. 2005; 46: 2069-2075
        • Iskandrian A.E.
        • Bateman T.M.
        • Belardinelli L.
        • Blackburn B.
        • Cerqueria M.D.
        • Hendel R.C.
        • Lieu H.
        • Mahmarian J.J.
        • Olmstead A.
        • Underwood R.
        • ADVANCE MPI Investigators
        Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.
        J Nucl Cardiol. 2007; 14: 645-658
        • Thomas G.S.
        • Tammelin B.R.
        • Schiffman G.L.
        • Marquez R.
        • Rice D.L.
        • Milikien D.
        • Mathur V.
        Safety of regadenoson, a selective A2A agonist, in patients with chronic obstructive pulmonary disease.
        J Nucl Cardiol. 2008; 15: 319-328
        • Leaker B.R.
        • O'Connor B.
        • Hansel T.T.
        • Barnes P.J.
        • Meng L.
        • Mathur V.S.
        • Lieu H.D.
        Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.
        J Nucl Cardiol. 2008; 15: 329-336
        • Rankin A.C.
        • Brooks R.
        • Ruskin J.
        Adenosine and the treatment of supraventricular tachycardia.
        Am J Med. 1992; 92: 655-664
        • Mahmarian J.J.
        • Dakik H.A.
        • Filipchuk N.G.
        • Shaw L.J.
        • Iskander S.S.
        • Ruddy T.D.
        • Keng F.
        • Henzlova M.J.
        • Allam A.
        • Moyé L.A.
        • Pratt C.M.
        • INSPIRE Investigators
        An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction.
        J Am Coll Cardiol. 2006; 48: 2458-2467
        • Mikhail G.W.
        Coronary heart disease in women.
        BMJ. 2005; 331: 467-468
        • Iskandrian A.E.
        • Gardia E.V.
        Nuclear Cardiac Imaging: Principles and Applications.
        4th ed. Oxford University Press, Oxford, United Kingdom2008
        • Zoghbi G.J.
        • Dorfman T.A.
        • Iskandrian A.E.
        The effects of medications on myocardial perfusion.
        J Am Coll Cardiol. 2008; 52: 401-416